Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.
Press releases published on August 28, 2025
EDAP Reports Strong Second Quarter 2025 HIFU Results
GlobeNewswire
·
August 28, 2025
+140% Focal One® Net Placement Growth Year over Year +76.8% HIFU Revenue Growth Year over Year 36 million Euro Credit Facility Letter of Intent Executed with European Investment Bank (EIB) to further accelerate HIFU Growth and Strategic Expansion Company …
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 28, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 28, 2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, …
AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025
GlobeNewswire
·
August 28, 2025
MILAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated LUCE-1 clinical data at the …
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 28, 2025
PHILADELPHIA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will participate in the …
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to …
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
GlobeNewswire
·
August 28, 2025
LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and …
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 28, 2025
CHATHAM, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that …
J-Star Holding Launches QO Bikes, a New Cycling Carbon Fiber Components Brand Co-Founded with Industry Veterans
GlobeNewswire
·
August 28, 2025
TAICHUNG CITY, Taiwan, Aug. 28, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, …
SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel
GlobeNewswire
·
August 28, 2025
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
GlobeNewswire
·
August 28, 2025
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA Outlook Therapeutics plans to work with FDA to address the Agency’s issues Company to host a conference call and webcast today, August 28th at 8:30 AM ET ISELIN, N.J., Aug. 28, 2025 ( …
KFSHRC Advances Nursing Excellence Through Specialized Training
GlobeNewswire
·
August 28, 2025
RIYADH, Saudi Arabia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL
GlobeNewswire
·
August 28, 2025
HYDERABAD, India, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new …
ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics.
GlobeNewswire
·
August 28, 2025
28. august 2025 Meddelelse ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics. Samarbejdet med Roche Diagnostics markerer det første væ …
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
GlobeNewswire
·
August 28, 2025
August 28, 2025 News Release ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics. Collaboration with Roche Diagnostics is first major commercial …
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
GlobeNewswire
·
August 28, 2025
TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 cancer-related deaths in the US are …
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet …
Dermatology Expert Laurel Leithauser, MD, FFAD, FACMS, Offers UV Protection and Skin Cancer Screening Advice in HelloNation
GlobeNewswire
·
August 28, 2025
TRAVERSE CITY, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Why should residents in Traverse City treat a skin cancer screening like any other annual health exam? In HelloNation, Dr. Laurel Leithauser of Leithauser Skin Institute explains why routine checkups …
Veterinary Expert Dr. Ben Nemmers Explains What Most People Don’t Realize About Boarding with Vet Care in HelloNation
GlobeNewswire
·
August 28, 2025
CEDAR FALLS, Iowa, Aug. 28, 2025 (GLOBE NEWSWIRE) -- What makes pet boarding with veterinary care different from a standard kennel stay? In HelloNation, Dr. Ben Nemmers of Companion Animal Clinic …
argenx to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext …